You are here

Amneal Pharmaceuticals

Member Since 2016

Chirag Patel

Co-Chairman & Co-Founder

 

Chirag’s lifelong drive and constant desire to discover what’s next has carried Amneal from humble beginnings to an emerging global presence. As the founder of two technology companies, his clear vision, steady guidance and boundless enthusiasm served as catalysts for the steady and continued expansion of Amneal. As the company continues to experience unprecedented growth, Amneal’s focus on quality, superb service levels, and building strong relationships holds firm and stands as testament to the strength of its reputation.

Chirag is the recipient of several industry honors including the 2011 Ernst & Young National Entrepreneur of the Year Life Sciences Award® and supports various philanthropic and charitable causes both in the U.S. and abroad. Chirag and his wife, Priti Patel, established the Niswarth Children Foundation in 2013, with the goal of bringing fresh water, sanitation, sustenance and education to one million underprivileged children in India. Chirag serves on the boards of the Generic Pharmaceutical Association, the Art of Living Foundation, New Jersey City University Foundation and the Family Reach Foundation.

Chirag received his bachelor’s degree in commerce from H.A. College of Commerce, India and his B.S. in business administration from New Jersey City University. He also received an honorary doctorate degree from New Jersey City University in recognition of his efforts to serve others and help them transform their lives.

     

Life Sciences Consortium

LSC  Task Force Participation

Member: Chirag Patel, Co-Chief Executive Officer & Co-Chairman, Co-Founder

Amneal Pharmaceuticals

Amneal Pharmaceuticals is seventh largest generic pharmaceutical manufacturer in the United States and the fastest growing generic company globally, according to IMS Health. Founded in 2002 in the United States by Chirag and Chintu Patel, the company has since grown to include offices in Australia, Europe and Asia. Amneal’s diversified portfolio includes high quality complex dosage forms, such as liquids, topicals, transdermals, injectables, and inhalation products. As Amneal continues to experience unprecedented growth, its focus on quality, superb service levels, and building strong relationships holds firm and stands as testament to the strength of its reputation. For more information, please visit www.amneal.com.